{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:08:08Z","timestamp":1794103688631,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Fecal coprolites preserve ancient microbiomes and are a potential source of extinct but highly efficacious antimicrobial peptides (AMPs). Here, we develop AMPLiT (AMP Lightweight Identification Tool), an efficient tool deployable to portable hardware for AMP screening in metagenomic datasets. AMPLiT demonstrates AUPRC performances of 0.9486\u2009\u00b1\u20090.0003 and reasonable overall training time of 3200\u2009\u00b1\u200953\u2009s. By computationally utilizing AMPLiT, we analyze seven ancient human coprolite metagenomes, identifying 160 AMP candidates. Of 40 representative peptides synthesized, 36 (90%) peptides demonstrate measurable antimicrobial activity at 100\u2009\u03bcM or less in vitro. Strikingly, approximately two-thirds of these peptides are sourced from\n                    <jats:italic>Segatella copri<\/jats:italic>\n                    , a dominant ancient gut commensal that is conspicuously underrepresented in modern populations, particularly those with Westernized lifestyles. Representative\n                    <jats:italic>S. copri<\/jats:italic>\n                    -derived AMPs exhibit disruptions against membranes of pathogenic bacteria, coupled with low cytotoxicity and hemolytic risk. In vivo, lead peptides demonstrate potent antibacterial and wound-healing efficacy comparable to traditional antibiotics, especially in combating gram-positive pathogens. Our findings highlight the ancient gut microbiomes as sources of novel AMPs, offering valuable insights into the historical role of\n                    <jats:italic>S. copri<\/jats:italic>\n                    in human health and its decline in contemporary populations.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-68495-0","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:55:54Z","timestamp":1768413354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Identification of antimicrobial peptides from ancient gut microbiomes"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0937-4873","authenticated-orcid":false,"given":"Sizhe","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3791-2305","authenticated-orcid":false,"given":"Ye","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7597-5062","authenticated-orcid":false,"given":"Hein Min","family":"Tun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9797-6493","authenticated-orcid":false,"given":"Zhimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8193-5198","authenticated-orcid":false,"given":"Yinglei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6428-5936","authenticated-orcid":false,"given":"Sunjae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8357-4629","authenticated-orcid":false,"given":"Xiaole","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"DeLeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene B.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis Ka Leung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8914-5879","authenticated-orcid":false,"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6850-4454","authenticated-orcid":false,"given":"Siew Chien","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9100-387X","authenticated-orcid":false,"given":"Qi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"68495_CR1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s41587-022-01226-0","volume":"40","author":"Y Ma","year":"2022","unstructured":"Ma, Y. et al. Identification of antimicrobial peptides from the human gut microbiome using deep learning. Nat. Biotechnol. 40, 921\u2013931 (2022).","journal-title":"Nat. Biotechnol."},{"key":"68495_CR2","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1038\/s41564-023-01524-6","volume":"8","author":"AM King","year":"2023","unstructured":"King, A. M. et al. Systematic mining of the human microbiome identifies antimicrobial peptides with diverse activity spectra. Nat. Microbiol. 8, 2420\u20132434 (2023).","journal-title":"Nat. Microbiol."},{"key":"68495_CR3","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.1016\/j.cell.2024.07.027","volume":"187","author":"MDT Torres","year":"2024","unstructured":"Torres, M. D. T. et al. Mining human microbiomes reveals an untapped source of peptide antibiotics. Cell 187, 5453\u20135467.e5415 (2024).","journal-title":"Cell"},{"key":"68495_CR4","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41551-024-01201-x","volume":"8","author":"F Wan","year":"2024","unstructured":"Wan, F., Torres, M. D. T., Peng, J. & de la Fuente-Nunez, C. Deep-learning-enabled antibiotic discovery through molecular de-extinction. Nat. Biomed. Eng. 8, 854\u2013871 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"68495_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01985-9","volume":"12","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. Screening and identification of antimicrobial peptides from the gut microbiome of cockroach Blattella germanica. Microbiome 12, 272 (2024).","journal-title":"Microbiome"},{"key":"68495_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau5480","volume":"368","author":"BP Lazzaro","year":"2020","unstructured":"Lazzaro, B. P., Zasloff, M. & Rolff, J. Antimicrobial peptides: application informed by evolution. Science 368, eaau5480 (2020).","journal-title":"Science"},{"key":"68495_CR7","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1021\/acs.jcim.1c00175","volume":"61","author":"PGA Aronica","year":"2021","unstructured":"Aronica, P. G. A. et al. Computational methods and tools in antimicrobial peptide research. J. Chem. Inf. Model. 61, 3172\u20133196 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"68495_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","volume":"19","author":"N Mookherjee","year":"2020","unstructured":"Mookherjee, N., Anderson, M. A., Haagsman, H. P. & Davidson, D. J. Antimicrobial host defence peptides: functions and clinical potential. Nat. Rev. Drug Discov. 19, 311\u2013332 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"68495_CR9","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.chom.2023.07.001","volume":"31","author":"JRMA Maasch","year":"2023","unstructured":"Maasch, J. R. M. A., Torres, M. D. T., Melo, M. C. R. & de la Fuente-Nunez, C. Molecular de-extinction of ancient antimicrobial peptides enabled by machine learning. Cell Host Microbe 31, 1260\u20131274.e1266 (2023).","journal-title":"Cell Host Microbe"},{"key":"68495_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/ng.2536","volume":"45","author":"CJ Adler","year":"2013","unstructured":"Adler, C. J. et al. Sequencing ancient calcified dental plaque shows changes in oral microbiota with dietary shifts of the Neolithic and Industrial revolutions. Nat. Genet. 45, 450\u2013455 (2013).","journal-title":"Nat. Genet."},{"key":"68495_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51464-w","volume":"15","author":"G Tesfaw","year":"2024","unstructured":"Tesfaw, G. et al. Gut microbiota patterns associated with duration of diarrhea in children under five years of age in Ethiopia. Nat. Commun. 15, 7532 (2024).","journal-title":"Nat. Commun."},{"key":"68495_CR12","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.chom.2024.10.017","volume":"32","author":"Y Peng","year":"2024","unstructured":"Peng, Y. et al. A metagenome-assembled genome inventory for children reveals early-life gut bacteriome and virome dynamics. Cell Host Microbe 32, 2212\u20132230.e2218 (2024).","journal-title":"Cell Host Microbe"},{"key":"68495_CR13","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.chom.2023.09.013","volume":"31","author":"A Blanco-M\u00edguez","year":"2023","unstructured":"Blanco-M\u00edguez, A. et al. Extension of the Segatella copri complex to 13 species with distinct large extrachromosomal elements and associations with host conditions. Cell Host Microbe 31, 1804\u20131819.e1809 (2023).","journal-title":"Cell Host Microbe"},{"key":"68495_CR14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.chom.2019.08.018","volume":"26","author":"A Tett","year":"2019","unstructured":"Tett, A. et al. The Prevotella copri complex comprises four distinct clades underrepresented in westernized populations. Cell Host Microbe 26, 666\u2013679.e667 (2019).","journal-title":"Cell Host Microbe"},{"key":"68495_CR15","doi-asserted-by":"publisher","unstructured":"Bosch Thomas, C. G. & Zasloff, M. Antimicrobial peptides\u2014Or how our ancestors learned to control the microbiome. mBio 12, https:\/\/doi.org\/10.1128\/mbio.01847-01821 (2021).","DOI":"10.1128\/mbio.01847-01821"},{"key":"68495_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrmicro1441","volume":"4","author":"A Peschel","year":"2006","unstructured":"Peschel, A. & Sahl, H.-G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4, 529\u2013536 (2006).","journal-title":"Nat. Rev. Microbiol."},{"key":"68495_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41586-021-03532-0","volume":"594","author":"MC Wibowo","year":"2021","unstructured":"Wibowo, M. C. et al. Reconstruction of ancient microbial genomes from the human gut. Nature 594, 234\u2013239 (2021).","journal-title":"Nature"},{"key":"68495_CR18","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1016\/j.cell.2024.05.013","volume":"187","author":"CD Santos-J\u00fanior","year":"2024","unstructured":"Santos-J\u00fanior, C. D. et al. Discovery of antimicrobial peptides in the global microbiome with machine learning. Cell 187, 3761\u20133778.e3716 (2024).","journal-title":"Cell"},{"key":"68495_CR19","doi-asserted-by":"publisher","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","volume":"44","author":"G Wang","year":"2016","unstructured":"Wang, G., Li, X. & Wang, Z. APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res. 44, D1087\u2013D1093 (2016).","journal-title":"Nucleic Acids Res."},{"key":"68495_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ads8932","volume":"11","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Discovery of antimicrobial peptides with notable antibacterial potency by an LLM-based foundation model. Sci. Adv. 11, eads8932 (2025).","journal-title":"Sci. Adv."},{"key":"68495_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac174","volume":"23","author":"N Sharma","year":"2022","unstructured":"Sharma, N., Naorem, L. D., Jain, S. & Raghava, G. P. S. ToxinPred2: an improved method for predicting toxicity of proteins. Brief. Bioinform. 23, bbac174 (2022).","journal-title":"Brief. Bioinform."},{"key":"68495_CR22","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.2174\/1381612824666180327165012","volume":"24","author":"P Elio","year":"2018","unstructured":"Elio, P., Valeria, C., Alberto Di, D. & Eugenio, N. Cryptic antimicrobial peptides: identification methods and current knowledge of their immunomodulatory properties. Curr. Pharm. Des. 24, 1054\u20131066 (2018).","journal-title":"Curr. Pharm. Des."},{"key":"68495_CR23","doi-asserted-by":"crossref","unstructured":"Zhu, Y. et al. Self-assembling peptide with dual function of cell penetration and antibacterial as a nano weapon to combat intracellular bacteria. Sci. Adv. 11, eads3844 (2025).","DOI":"10.1126\/sciadv.ads3844"},{"key":"68495_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1021\/acsinfecdis.1c00536","volume":"8","author":"JE Nielsen","year":"2022","unstructured":"Nielsen, J. E. et al. Self-assembly of antimicrobial peptoids impacts their biological effects on ESKAPE bacterial pathogens. ACS Infect. Dis. 8, 533\u2013545 (2022).","journal-title":"ACS Infect. Dis."},{"key":"68495_CR25","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1039\/D0CS00729C","volume":"50","author":"BH Gan","year":"2021","unstructured":"Gan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T. & Spring, D. R. The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions. Chem. Soc. Rev. 50, 7820\u20137880 (2021).","journal-title":"Chem. Soc. Rev."},{"key":"68495_CR26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41551-021-00689-x","volume":"5","author":"P Das","year":"2021","unstructured":"Das, P. et al. Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations. Nat. Biomed. Eng. 5, 613\u2013623 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"68495_CR27","doi-asserted-by":"publisher","first-page":"msae017","DOI":"10.1093\/molbev\/msae017","volume":"41","author":"I Jackson","year":"2024","unstructured":"Jackson, I., Woodman, P., Dowd, M., Fibiger, L. & Cassidy, L. M. Ancient genomes from Bronze Age remains reveal deep diversity and recent adaptive episodes for human oral pathobionts. Mol. Biol. Evol. 41, msae017 (2024).","journal-title":"Mol. Biol. Evol."},{"key":"68495_CR28","doi-asserted-by":"publisher","first-page":"101229","DOI":"10.1016\/j.nantod.2021.101229","volume":"39","author":"P Tan","year":"2021","unstructured":"Tan, P., Fu, H. & Ma, X. Design, optimization, and nanotechnology of antimicrobial peptides: from exploration to applications. Nano Today 39, 101229 (2021).","journal-title":"Nano Today"},{"key":"68495_CR29","doi-asserted-by":"publisher","first-page":"D377","DOI":"10.1093\/nar\/gkac933","volume":"51","author":"U Gawde","year":"2023","unstructured":"Gawde, U. et al. CAMPR4: a database of natural and synthetic antimicrobial peptides. Nucleic Acids Res. 51, D377\u2013D383 (2023).","journal-title":"Nucleic Acids Res."},{"key":"68495_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066557","volume":"8","author":"X Zhao","year":"2013","unstructured":"Zhao, X., Wu, H., Lu, H., Li, G. & Huang, Q. LAMP: a database linking antimicrobial peptides. PLoS ONE 8, e66557 (2013).","journal-title":"PLoS ONE"},{"key":"68495_CR31","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.chom.2023.10.009","volume":"31","author":"Y Peng","year":"2023","unstructured":"Peng, Y. & Tun, H. M. Meet the extended Segatella copri complex. Cell Host Microbe 31, 1766\u20131769 (2023).","journal-title":"Cell Host Microbe"},{"key":"68495_CR32","doi-asserted-by":"publisher","DOI":"10.1177\/17562848221136328","volume":"16","author":"A Lo Presti","year":"2023","unstructured":"Lo Presti, A. et al. Phylogenetic analysis of Prevotella copri from fecal and mucosal microbiota of IBS and IBD patients. Ther. Adv. Gastroenterol. 16, 17562848221136328 (2023).","journal-title":"Ther. Adv. Gastroenterol."},{"key":"68495_CR33","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/annrheumdis-2018-214514","volume":"78","author":"D Alpizar-Rodriguez","year":"2019","unstructured":"Alpizar-Rodriguez, D. et al. Prevotella copri in individuals at risk for rheumatoid arthritis. Ann. Rheum. Dis. 78, 590\u2013593 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"68495_CR34","doi-asserted-by":"publisher","first-page":"D670","DOI":"10.1093\/nar\/gku1177","volume":"43","author":"KR Rosenbloom","year":"2015","unstructured":"Rosenbloom, K. R. et al. The UCSC Genome Browser database: 2015 update. Nucleic Acids Res. 43, D670\u2013D681 (2015).","journal-title":"Nucleic Acids Res."},{"key":"68495_CR35","doi-asserted-by":"crossref","unstructured":"Prjibelski, A., Antipov, D., Meleshko, D., Lapidus, A. & Korobeynikov, A. Using SPAdes de novo assembler. Curr. Protoc. Bioinform. 70, e102 (2020).","DOI":"10.1002\/cpbi.102"},{"key":"68495_CR36","doi-asserted-by":"publisher","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","volume":"53","author":"The UniProt, C","year":"2025","unstructured":"The UniProt, C UniProt: the Universal Protein Knowledgebase in 2025. Nucleic Acids Res. 53, D609\u2013D617 (2025).","journal-title":"Nucleic Acids Res."},{"key":"68495_CR37","doi-asserted-by":"publisher","first-page":"D288","DOI":"10.1093\/nar\/gkaa991","volume":"49","author":"M Pirtskhalava","year":"2021","unstructured":"Pirtskhalava, M. et al. DBAASP v3: database of antimicrobial\/cytotoxic activity and structure of peptides as a resource for development of new therapeutics. Nucleic Acids Res. 49, D288\u2013D297 (2021).","journal-title":"Nucleic Acids Res."},{"key":"68495_CR38","doi-asserted-by":"crossref","unstructured":"Chan, W. & White, P. Fmoc Solid Phase Peptide Synthesis: a Practical Approach (Oxford University Press, 1999).","DOI":"10.1093\/oso\/9780199637256.001.0001"},{"key":"68495_CR39","unstructured":"Wayne, P. A. Performance Standards for Antimicrobial Disk Susceptibility Tests (Clinical and Laboratory Standards Institute, 2012)."},{"key":"68495_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01605-y","volume":"11","author":"M Li","year":"2023","unstructured":"Li, M. et al. Lactiplantibacillus plantarum enables blood urate control in mice through degradation of nucleosides in gastrointestinal tract. Microbiome 11, 153 (2023).","journal-title":"Microbiome"},{"key":"68495_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01578-y","volume":"11","author":"AL Degraeve","year":"2023","unstructured":"Degraeve, A. L. et al. Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1. Microbiome 11, 138 (2023).","journal-title":"Microbiome"},{"key":"68495_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2434685","volume":"17","author":"E Floor","year":"2025","unstructured":"Floor, E. et al. Development of a Caco-2-based intestinal mucosal model to study intestinal barrier properties and bacteria-mucus interactions. Gut Microbes 17, 2434685 (2025).","journal-title":"Gut Microbes"},{"key":"68495_CR43","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nprot.2017.041","volume":"12","author":"A Beloqui","year":"2017","unstructured":"Beloqui, A., Brayden, D. J., Artursson, P., Pr\u00e9at, V. & des Rieux, A. A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation. Nat. Protoc. 12, 1387\u20131399 (2017).","journal-title":"Nat. Protoc."},{"key":"68495_CR44","doi-asserted-by":"crossref","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","DOI":"10.1038\/s41586-024-07487-w"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68495-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68495-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68495-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:54:36Z","timestamp":1771426476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68495-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68495"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68495-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.C.N. has served as an advisory board member for Pfizer, Ferring, Janssen and Abbvie and received honoraria as a speaker for Ferring, Tillotts, Menarini, Janssen, Abbvie and Takeda; has received research grants through her affiliated institutions from Olympus, Ferring and Abbvie; is a founder member, non-executive director, non-executive scientific advisor and shareholder of GenieBiome Ltd which is non-remunerative; is a shareholder of MicroSigX Diagnostic Holding Limited; is a founder member, non-executive Board Director, and non-executive scientific advisor of MicroSigX Biotech Diagnostic Limited, which is non-remunerative; and receives patent royalties through her affiliated institutions. F.K.L.C. serves as the Principal Investigator for the Fecal Microbiota Transplantation Service under the Hospital Authority (HA). He is a Board Director of EHealth Plus Digital Technology Ltd., an HA-owned subsidiary driving the eHealth+ program to transform the Electronic Health Record Sharing System into a comprehensive digital healthcare platform and advance other IT initiatives within the eHealth ecosystem. Additionally, he is a Board Director of CUHK Medical Services Limited. F.K.L.C. is a shareholder of GenieBiome Holdings Limited and the co-founder, non-executive Board Chairman, and non-executive Scientific Advisor of its wholly owned subsidiary, GenieBiome Ltd. Similarly, he is a shareholder of MicroSigX Diagnostic Holding Limited and the co-founder, non-executive Board Chairman, and non-executive Scientific Advisor of its wholly owned subsidiary, MicroSigX Biotech Diagnostic Limited. He also serves as a Director of the Hong Kong Investment Corporation Limited and a member of the Steering Committee for the RAISe+ Scheme under the Innovation and Technology Commission. Furthermore, he is the Co-Director of the Microbiota I-Center (MagIC) Ltd. FKLC receives advisory fees and speaker honoraria from AstraZeneca and Comvita New Zealand Limited, as well as patent royalties through affiliated institutions for microbiome-related applications. F.K.L.C., S.C.N., and H.M.T. are named inventors of patent applications held by the CUHK and MagIC that cover the therapeutic and diagnostic use of the microbiome. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1788"}}